Microarray profile analysis of toxic cocaine-induced alterations in the expression of mouse brain gene sequences: A possible 'protective' effect of Buprenorphine

Journal of Applied Toxicology

Volumn 24, Issue 1, 2004, Pages 15-20

  Hayase, Tamaki ^a   Yamamoto, Yoshiko ^a   Yamamoto, Keiichi ^a   Muso, Eri ^a   Shiota, Kohei ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Buprenorphine; cDNA microarray; Cocaine toxicity; Dysfunction in neural cells; Gene expression profile; Mouse brain

Indexed keywords

BUPRENORPHINE; COCAINE; COMPLEMENTARY DNA; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CONVULSION; DISEASE SEVERITY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE INDUCTION; GENE MUTATION; GENE SEQUENCE; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; STATISTICAL SIGNIFICANCE;

ANIMALS; BUPRENORPHINE; COCAINE; COCAINE-RELATED DISORDERS; DRUG THERAPY, COMBINATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED ICR; NARCOTIC ANTAGONISTS; NARCOTICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEIZURES; TELENCEPHALON;

EID: 0842344496     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jat.939     Document Type: Article

References (35)

1. Adams J, Collaco-Moraes Y, de Belleroche J. 1996. Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitaion. J. Neurochem. 66: 6-13.
2. Baker DA, Fuchs RA, Tran-Nguyen LT, Palmer AJ, Marshall JF, McPherson RJ, Neisewander JL. 1999. Cocaine-seeking behavior and Fos expression in the amygdala produced by cocaine or a cocaine self-administration environment. Ann. NY Acad. Sci. 877: 796-799.
3. Belcheva MM, Ho MT, Ignatova EG, Jefcoat LB, Barg J, Vogel Z, McHale RJ, Johnson FE, Coscia CJ. 1996. Buprenorphine differentially alters opioid receptor adaptation in rat brain regions. J. Pharmacol. Exp. Ther. 277: 1322-1327.
4. Belcheva MM, Bohn LM, Ho MT, Johnson FE, Yanai J, Barron S, Coscia CJ. 1998. Brain opioid receptor adaptation and expression after prenatal exposure to buprenorphine. Brain Res. Dev. Brain Res. 111: 35-42.
5. Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, Glynne R, Henderson MA, Armes JE, Venter DJ. 2002. Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res. 62: 1289-1295.
6. Boyer CS, Petersen DR. 1992. Enzymatic basis for the transesterification of cocaine in the presence of ethanol: evidence for the participation of microsomal carboxylesterases. J. Pharmacol. Exp. Ther. 260: 939-946.
7. Castronuovo JJ Jr, Price RM. 2002. The sequence of gene expression in cultured human saphenous vein after injury. J. Vasc. Surg. 35: 146-151.
8. Cunningham MJ, Liang S, Fuhrman S, Seilhamer JJ, Somogyi R. 2000. Gene expression microarray data analysis for toxicology profiling. Ann. NY Acad. Sci. 919: 52-67.
9. Daunais JB, McGinty JF. 1996. The effects of D1 or D2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge. Mol. Brain Res. 35: 237-248.
10. Donovan DM, Miner LL, Perry MP, Revay RS, Sharpe LG, Przedborski S, Kostic V, Philpot RM, Kirstein CL, Rothman RB, Schindler CW, Uhl GR. 1999. Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression. Brain Res. Mol. Brain Res. 73: 37-49.
11. Graybiel AM, Moratalla R, Robertson HA. 1990. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA 87: 6912-6916.
12. Greenfield S. 1996. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28: 485-490.
13. Gubellini P, Bisso GM, Ciofi-Luzzatto A, Fortuna S, Lorenzini P, Michalek H, Scarsella G. 1997. Ubiquitin-mediated stress response in a rat model of brain transient ischemia/hypoxia. Neurochem. Res. 22: 93-100.
14. Hayase T, Yamamoto Y, Yamamoto K, Abiru H, Nishitani Y, Fukui Y. 2000. Relationship between cocaine-induced hepatotoxic neurobehavioral & biochemical changes in mice: the antidotal effects of buprenorphine. Life Sci. 67: 45-52.
15. Hayase T, Yamamoto Y, Yamamoto K. 2001. Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-incluced toxic behavioural symptoms. J. Pharm. Pharmacol. 53: 1525-1532.
16. Helton TE, Daunais JB, McGinty JF. 1993. Convulsant doses of cocaine alter immediate early gene and opioid peptide expression in rat limbic forebrain. Mol. Brain Res. 20: 285-288.
17. Holz A, Bielekova B, Martin R, Oldstone MB. 2000. Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosis. J. Immunol. 164: 1103-1109.
18. Jones MK, Ross DT. 1995. The partial mu opiate agonist buprenorphine protects a sub-population of thalamic reticular neurons following cardiac arrest in rats. Neurosci. Lett. 185: 91-94.
19. Keys AS, Mark GP, Emre N, Meshul CK. 1998. Reduced glutamate immunolabeling in the nucleus accumbens following extended withdrawal from self-administered cocaine. Synapse. 30: 393-401.
20. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S. 1998. Hypothalamic CART is a new anorectic pepticle regulated by leptin. Nature. 393: 72-76.
21. Kunz WS. 2002. The role of mitochondria in epileptogenesis. Curr. Opin. Neurol. 15: 179-184.
22. Kuzmin A, Johansson B. 1999. Expression of c-fos, NGFI-A and secretogranin II mRNA in brain regions during initiation of cocaine self-administration in mice. Eur. J. Neurosci. 11: 3694-3700.
23. Matsumoto RR, McCracken KA, Pouw B, Miller J, Bowen WD, Williams W, De Costa BR. 2001. N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice. Eur. J. Pharmacol. 411: 261-273.
24. O'Neill MF, Hicks CA, Shaw G, Parameswaran T, Cardwell GP, O'Neill MJ. 1998. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine. J. Pharmacol. Exp. Ther. 287: 839-846.
25. Planas AM, Soriano MA, Ferrer I, Rodriguez Farré E. 1994. Regional expression of inducible heat shock protein-70 mRNA in the rat brain following administration of convulsant drugs. Mol. Brain Res. 27: 127-137.
26. Reilly TP, Bourdi M, Brady JN, Pise-Masison CA, Radonovich MF, George JW, Pohl LR. 2001a. Expression profiling of acetaminophen liver toxicity in mice using microarray technology. Biochem. Biophys. Res. Commun. 282: 321-328.
27. Reilly TP, Brady JN, Marchick MR, Bourdi M, George JW, Radonovich MF, Pise-Masison CA, Pohl LR. 2001b. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem. Res. Toxicol. 14: 1620-1628.
28. Rihn BH, Mohr S, McDowell SA, Binet S, Loubinoux J, Galateau F, Keith G, Leikauf GD. 2000. Differential gene expression in mesothelioma. FEBS Lett. 480: 95-100.
29. Sañudo-Peña MC, Romero J, Seale GE, Fernandez-Ruiz JJ, Walker JM. 2000. Activational role of cannabinoids on movement. Eur. J. Pharmacol. 391: 269-274.
30. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF. 2001. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res. 61: 4375-4381.
31. Shukla VK, Goldfrank LR, Turndorf H, Bansinath M. 1991. Antagonism of acute cocaine toxicity by buprenorphine. Life Sci. 49: 1887-1893.
32. Staley JK, Hearn WL, Ruttenber AJ, Wetli CV, Mash DC. 1994. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J. Pharmacol. Exp. Ther. 271: 1678-1685.
33. Wilder RL, Griffiths MM, Cannon GW, Caspi R, Remmers EF. 2000. Susceptibility to autoimmune disease and drug addiction in inbred rats. Are there mechanistic factors in common related to abnormalities in hypothalamic-pituitary-adrenal axis and stress response function? Ann. NY Acad. Sci. 917: 784-796.
34. Xia Y, Goebel DJ, Kapatos G, Bannon MJ. 1992. Quantitation of rat dopamine transporter mRNA: effects of cocaine treatment and withdrawal. J. Neurochem. 59: 1179-1182.
35. Yoshikawa T, Nagasugi Y, Azuma T, Kato M, Sugano S, Hashimoto K, Masuho Y, Muramatsu M, Saki N. 2000. Isolation of novel mouse genes differentially expressed in brain using cDNA microarray. Biochem. Biophys. Res. Commun. 275: 532-537.